You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • AB0213 Is Disease Duration An Independent Predictor of Low Disease Activity/remission among Biologic-Naïve Patients with Rheumatoid Arthritis Treated with Abatacept?

Citation Tools

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Rheumatoid arthritis - prognosis, predictors and outcome
AB0213 Is Disease Duration An Independent Predictor of Low Disease Activity/remission among Biologic-Naïve Patients with Rheumatoid Arthritis Treated with Abatacept?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Harrold L, Litman H, Connolly S, et al
AB0213 Is Disease Duration An Independent Predictor of Low Disease Activity/remission among Biologic-Naïve Patients with Rheumatoid Arthritis Treated with Abatacept?
Annals of the Rheumatic Diseases 2016;75:970.